Expert Ratings For Amgen - Nasdaq

Jun 14, 2024 · In the latest quarter, 11 analysts provided ratings for Amgen (NASDAQ:AMGN), ... Expert Ratings For Amgen June 14, 2024 — 01:00 pm EDT.

CouponFollow Extension

$338.45
OFF

In-Depth Examination Of 11 Analyst Recommendations For …

1 week from now

Oct 14, 2024 · In the assessment of 12-month price targets, analysts unveil insights for Amgen, presenting an average target of $338.45, a high estimate of $405.00, and a low estimate of …

nasdaq.com

$260.52
OFF

Amgen (NASDAQ:AMGN) Stock Rating Upgraded By Citigroup

1 week from now

3 days ago · Amgen has a 12 month low of $260.52 and a 12 month high of $346.85. The company has a market capitalization of $159.07 billion, a PE ratio of 37.89, a price-to-earnings …

marketbeat.com

83%
OFF

Amgen (AMGN) Stock Forecast And Price Target 2024 - MarketBeat

1 week from now

3 days ago · Amgen Inc. announced a quarterly dividend, with a yield of 2.83%. This dividend payout can provide investors with a steady income stream, enhancing the overall return on …

marketbeat.com

$283.61
OFF

Amgen Inc. (NASDAQ:AMGN) Receives Average ... - ETF Daily News

1 week from now

23 hours ago · Shares of AMGN opened at $283.61 on Friday. The company has a debt-to-equity ratio of 7.55, a quick ratio of 0.96 and a current ratio of 1.32. The firm’s 50-day simple moving …

etfdailynews.com

$315.27
OFF

AMGN Crosses Above Average Analyst Target - Nasdaq

1 week from now

Jun 25, 2024 · In recent trading, shares of Amgen Inc (Symbol: AMGN) have crossed above the average analyst 12-month target price of $315.27, changing hands for $318.15/share. When a …

nasdaq.com

$335
OFF

Amgen Initiated With A Neutral At Citi - Nasdaq

1 week from now

4 days ago · Citi initiated coverage of Amgen (AMGN) with a Neutral rating and $335 price target The company’s growth picture hinges on MariTide clinical success and to a lesser degree, the …

nasdaq.com

FAQs about Expert Ratings For Amgen - Nasdaq Coupon?

How have analysts rated Amgen (AMGN)?

Analysts have provided the following ratings for Amgen (NASDAQ:AMGN) within the last quarter: In the last 3 months, 9 analysts have offered 12-month price targets for Amgen. The company has an average price target of $278.44 with a high of $320.00 and a low of $223.00. Below is a summary of how these 9 analysts rated Amgen over the past 3 months. ...

How do analysts evaluate Amgen (Amgen) stock?

Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Amgen compared to the broader market. Price Targets: Analysts predict movements in price targets, offering estimates for Amgen's future value. ...

Should you buy Amgen (AMGN)?

24 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Amgen in the last year. There is currently 1 sell rating, 11 hold ratings, 11 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" AMGN shares. ...

How much does Amgen stock cost?

According to the research reports of 24 Wall Street equities research analysts, the average twelve-month stock price forecast for Amgen is $333.50, with a high forecast of $405.00 and a low forecast of $215.00. Should I buy or sell Amgen stock right now? ...

What is the price target for Amgen (AMGN)?

The highest price target for AMGN is $405.00, while the lowest price target for AMGN is $215.00. The average price target represents a forecasted upside of 5.23% from the current price of $316.91. Enter your email address to receive the latest news and analysts' ratings for Amgen and its competitors. Discover the coin set to explode before 2025! ...

Are Amgen insiders buying or selling stock?

In the past three months, Amgen insiders have not sold or bought any company stock. Only 0.69% of the stock of Amgen is held by insiders. 76.50% of the stock of Amgen is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Receive AMGN Stock News and Ratings via Email ...